NYU Langone Health is a 2,270-bed academic health system distinguished by sustained national leadership in quality, safety, research growth and clinical innovation. The system maintains a 5-star CMS quality rating, and is among an elite group of organizations with Magnet recognition across all hospitals. Its clinical enterprise delivers nationally ranked care in 13 specialties according to U.S. News & World Report for 2025-26, including No. 1 rankings in neurology/neurosurgery and a tie for No. 1 in pulmonology and lung surgery, while Rusk Rehabilitation remains the top program in New York and among the top five nationwide. NYU Langone advances groundbreaking science, including major National Institutes of Health-funded initiatives in dementia, cancer and transplantation. The system also achieved a historic milestone when its surgical team performed the nation’s first fully robotic lung transplant, followed by the world’s first robotic double lung transplant. The system pairs research leadership with broad community impact, contributing $2.7 billion in community benefit in fiscal year 2023 and sustaining comprehensive programs that address social determinants of health. NYU Langone also leads in environmental stewardship, having reduced carbon emissions by 40% since 2005 and becoming the first New York City–based member of the Health Care Climate Council. Recent innovations include AI-enabled cardiovascular risk detection using opportunistic CT screening, a systemwide digital pathology program that expands diagnostic capacity and efficiency, and teledermoscopy technology that increases access to early melanoma detection. NYU Langone additionally achieved a global breakthrough in xenotransplantation by sustaining a gene-edited pig kidney transplant for more than four months, the longest such case to date.
